Molecular Characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and Impact of T-Cell Epitope Mutations on HLA Recognition (ANRS 12159) by Lazaro, Estibaliz et al.
Molecular Characterization of HIV-1 CRF01_AE in
Mekong Delta, Vietnam, and Impact of T-Cell Epitope
Mutations on HLA Recognition (ANRS 12159)
Estibaliz Lazaro
1., Luong Thu Tram
2., Pantxika Bellecave
1, Gwenda-Line Guidicelli
3, Guerric Anies
3,4,
Huynh Hoang Khanh Thu
2, Marie Pillot Debelleix
1, Muriel Vray
5, Patricia Recordon-Pinson
1, Jean-Luc
Taupin
3,4, Truong Thi Xuan Lien
2, Herve Fleury
1*
1Laboratoire de Virologie, CHU de Bordeaux et CNRS-UMR 5234, Universite ´ Victor Segalen-Bordeaux 2, Bordeaux, France, 2Pasteur Institute, Ho Chi Minh City, Vietnam,
3Laboratoire d’immunologie et immunoge ´ne ´tique, CHU de Bordeaux, Bordeaux, France, 4CNRS-UMR 5164, Universite ´ Victor Segalen-Bordeaux 2, Bordeaux, France,
5Institut Pasteur, Paris, France
Abstract
Background: To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The
underlying reason why their distribution is so heterogeneous is not clear. Host genetic factors could partly explain this
distribution. The aim of this study was to describe HIV-1 strains circulating in an unexplored area of Mekong Delta, Vietnam,
and to assess the impact of optimal epitope mutations on HLA binding.
Methods: We recruited 125 chronically antiretroviral-naive HIV-1-infected subjects from five cities in the Mekong Delta. We
performed high-resolution DNA typing of HLA class I alleles, sequencing of Gag and RT-Prot genes and phylogenetic
analysis of the strains. Epitope mutations were analyzed in patients bearing the HLA allele restricting the studied epitope.
Optimal wild-type epitopes from the Los Alamos database were used as reference. T-cell epitope recognition was predicted
using the immune epitope database tool according to three different scores involved in antigen processing (TAP and
proteasome scores) and HLA binding (MHC score).
Results: All sequences clustered with CRF01_AE. HLA class I genotyping showed the predominance of Asian alleles as
A*11:01 and B*46:01 with a Vietnamese specificity held by two different haplotypes. The percentage of homology between
Mekong and B consensus HIV-1 sequences was above 85%. Divergent epitopes had TAP and proteasome scores comparable
with wild-type epitopes. MHC scores were significantly lower in divergent epitopes with a mean of 2.4 (60.9) versus 2 (60.7)
in non-divergent ones (p,0.0001).
Conclusions: Our study confirms the wide predominance of CRF01_AE in the Mekong Delta where patients harbor a specific
HLA pattern. Moreover, it demonstrates the lower MHC binding affinity among divergent epitopes. This weak immune
pressure combined with a narrow genetic diversity favors immune escape and could explain why CRF01_AE is still
predominant in Vietnam, particularly in the Mekong area.
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Introduction
Since its introduction in humans, HIV-1 has undergone
dramatic diversification, extensively spreading in all the continents
and rapidly diversifying in Caucasian, African and Asian
populations. The radial evolution of group M has led to multiple
clades or subtypes (A1, A2, B, C, D, F1, F2, G, H, J and K), all of
which are circulating in African populations. To date, 11 HIV-1
subtypes and 48 circulating recombinant forms have been
described worldwide. HIV-1 subtype B predominates in the Caucasian
populations ofEurope and the Americas, HIV-1subtypeCinSouth
Asia and CRF01_AE in South East Asia. In particular, a large
number of HIV-1 recombinants between subtypes B and C
(including CRF07_BC and CRF08_BC) are largely responsible
for the current AIDS epidemic in China [1], [2]. The underlying
reason why the distribution of the different HIV-1 subtypes is so
heterogeneous and unbalanced is not clear. Viral lineage, defined as
the founder effect, is certainly an important driver of HIV-1
evolution [3] but cannot explain all virus-clade-specific differences,
which are also the consequence, at least in part, of the worldwide
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e26244HLA distribution. The rapid spread of some subtypes and/or
recombinants in Oriental populations could be due to the relative
genetic homogeneity of these populations, which contrasts with the
extreme genetic diversity in Africans [4], [5], [6].
HLA class I molecules play a critical role in defining the
epitopes of cytotoxic T lymphocytes (CTLs), which are essential in
host viral defense against HIV [7]. Large cohort studies have
shown that certain HLA class I alleles correlate with HIV control,
HLA B*57:01 being the most consistently recognized association
with immune control of infection [8], [9], [10], [11]. Moreover,
homozygosity is associated with faster progression to AIDS,
suggesting that heterozygosity at each HLA class I allele allows the
presentation of a greater range of epitopes and a more effective
control of HIV replication [12], [13].
Mutations affecting HLA-restricted epitopes may lead to
immune escape if they impact on epitope antigen processing,
HLA binding or TCR recognition. Several studies have identified
a growing number of epitope mutations leading to immune escape,
especially in Caucasian populations infected with subtype B or
African populations infected with subtype C [14], [15], [16].
In Vietnam, we and others have demonstrated that CRF01_AE
is widely predominant, but little is known about the impact of
epitope mutations observed among Asian HIV-1 infected patients
on CTL recognition [17], [18], [19], [20].
The aim of this study was (i) to describe HIV-1 subtypes
circulating among antiretroviral (ART)-naive patients in an
unexplored area, the Mekong Delta, Vietnam; (ii) to analyze the
polymorphism of Gag and RT-Prot sequences; and (iii) to study
the impact of amino acid divergences within CRF01_AE epitopes
on antigen processing and HLA binding among this host
Vietnamese population.
Methods
Ethical statement
This study was approved by the Ethics Committee of the
Vietnamese Ministry of Public Health and was conducted in
accordance with the set guidelines for research. All patients
provided their written informed consent for the collection of the
samples and their subsequent analysis.
Population and samples
From June to October 2008, 125 chronically HIV-1-infected
individuals including 80 men and 45 women were recruited from 5
centers for preventive medicine located in the provincial cities of the
Mekong Delta (Vietnam): Dong Nai, Vung Tau, Tien Giang, An
Giang and Dong Thap (Figure 1). Most (95.2%) of these
individuals are drug users or sexually transmitted disease patients.
The median age was 30 (20–50) years. All patients except for 3
individuals who were receiving treatment are antiretroviral therapy
(ART)-naı ¨ve.
Blood samples were collected from each patient using
ethylenediaminetetraaceticacid (EDTA)tubes.CD4T lymphocytes
were counted with a FACScan flow cytometer (BD Biosciences, San
Jose, CA). The plasmasamples were separatedand stored at 280uC
until use.
The median CD4+ cell count in our study population was 147
cells/ml (1–1032) and the plasma viral load was unknown. Clinical
staging was as follows according to the WHO classification: 33%
stage I, 27% stage II, 35% stage III, 5% stage IV.
HLA class I typing
Genomic DNA was extracted from the frozen white blood cell
pellets using the MagNA Pure automatic system (Roche) according
to the manufacturer’s specifications, and quantitated by UV
optical density measurement. Intermediate-to-high resolution
was performed by reverse Polymerase Chain Reaction-Sequence
Specific Oligonucleotide (PCR-SSO) hybridization using the
LuminexH flow beads LabTypeH assay (InGen, Chilly-Mazarin,
France) for the A, B and Cw loci. Allelic ambiguities were
solved with PCR-Sequence Specific Primer (SSP) amplification
using Olerup assays (BioNoBis, Montfort L’Amaury, France). The
manufacturers’ recommendations were strictly followed. Allele
assignment was performed by comparison with the official nomen-
clature of April 2010 and validated by the WHO committee for
HLA system factors [21].
Allele frequencies and linkage disequilibrium
Allele and haplotype frequencies as well as linkage disequilib-
rium between all pairs of HLA loci were obtained with the HLA
Frequency Analysis Tool of the Los Alamos HIV Immunology
Figure 1. Vietnamese cities of Mekong Delta taking part to the study.
doi:10.1371/journal.pone.0026244.g001
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links.html). Frequency data for other populations were obtained
from previous studies: Kinh Vietnamese [22], Chinese and
European [23].
PCR amplification of HIV-1 Prot, Gag and RT, and
sequencing
Viral RNA was extracted from 200 ml of plasma samples using
the MagNA Pure LC Total Nucleic Acid Isolation-High
Performance kit with the MagNA Pure LC system ((Roche
Diagnostics, Mannheim, Germany). HIV regions were amplified
by RT-PCR using the Titan One Tube kit (Roche Diagnosis,
Mannheim, Germany) followed by nested PCR using the
Amplitaq Gold with GeneAmp Kit (Applied Biosystem, Foster
City, CA). The protease gene was amplified and sequenced
according to the ANRS procedure and Gag gene as previously
described [18]. The whole RT gene was obtained by using 3 sets of
primers, corresponding to polymerase (outer primers: MJ3 59-
AGTAGGACCTACACCTGTCA-39 and MJ4 59-CTGTTAGT-
GCTTTGGTTCCTCT-39; inner primers: A(35) 59-TTGGTTG-
CACTTTAAATTTTCCCATTAGTCCTATT-39 and NE1(35)
59-CCTACTAACTTCTGTATGTCATTGACAGTCCAGCT-
39), thumb-connection (outer primers: 02TCRT5 59-GGATG-
GAAAGGATCACCAGCAAT-39 and 02TCRT3 59-TGATT-
TGTTGTCTCAGTTAGGGAA-3 inner primers: 02TCnes5 59-
TGGATGGGATATGAACTCCATCCTGA-39 and 02TCnes3
59-TTAGCTGCCCCATCTACATCG-39 and RNase H domains
(outer primers: 02RNRT5 59-AAATATGCAAAAAGGAGGTC-
TGC-39 and 02RNRT3 59-CAGTCTACTTGTCCATGCAT-
GGC-39; inner primers: 02RNnes5 59-GAAACATGGGAAG-
CATGGTGGATGGAGTA-39 and 02RNnes3 59-TCTTCTT-
GGGCTTTATCTATGCCATCTA-39. PCR products were se-
quenced on both strands using a CEQ DTCS Quick Start kit on
an automated sequencer Beckman CEQ 2000 DNA analyzer
system (Beckman Coulter, Fullerton, CA) as previously described
[18]. Genotypic resistance was interpreted with the ANRS
algorithm v18.
Phylogenetic analysis
The derived nucleotide sequences of RT, Prot and Gag regions
were aligned by the Clustal W 1.74 alignment program with known
reference strains of M, N and O pooled from the HIV Database
(http://www.hiv.lanl.gov/). Phylogenetic trees were inferred by the
neighbor-joining method from matrix distances calculated after gap
stripping of alignments, according to a Kimura two-parameter
algorithm. The circular trees were obtained using the on-line tool
ITOL (http://itol.embl.de/) [24].
GenBank accession numbers for the sequences reported in this
study are HQ542709 to HQ542803, HQ542613 to HQ542708
and HQ542545 to HQ542612 for RT, Prot and Gag sequences
respectively.
Sequence alignment and consensus
Protein sequence analyses were performed using tools available
at the Institut de Biologie et Chimie des Prote ´ines (IBCP) Network
Protein Sequence Analysis (NPSA) website (http://npsa-pbil.ibcp.
fr) [25]. Multiple-sequence alignments of protein sequences
obtained from patients were performed with ClustalW using
default parameters. A primary consensus Mekong sequence was
generated for Gag, RT and Prot and was used for alignment with
consensus B and HxB2 strains. Identity was determined as a
percentage of strictly conserved amino acids between the two
sequences compared.
Immune recognition tools
The immune epitope database (www.immuneepitope.org) was
used to predict T-cell epitope recognition. The different steps
involved in the MHC class I antigen presentation pathway were
evaluated by three scores: the proteasomal score reflects the
efficiency of antigen-processing by the total amount of cleavage
site usage releasing the peptide C-terminus; the TAP score predicts
transporter associated with antigen processing (TAP) transport by
estimating the binding of a peptide or its N-terminal prolonged
precursors to TAP, with highest affinity for a peptide meaning the
highest transport rates; the MHC score defines the epitope affinity
for the MHC molecule. All scores are logarithmic values with
higher values indicating higher predicted efficiency.
Statistical analysis
Comparisons between the two groups were performed with the
paired t-test using GraphPad Prism version 4.00 for Macintosh
(GraphPad Software, San Diego, CA, USA). A p#0.05 was
considered as statistically significant.
Results
Sequence analysis
Sequence genotyping was performed for 105 samples. All RT,
Prot and Gag sequences clustered with subtype CRF01_AE
(depicted for RT gene in Figure 2, data not shown for the other
genes). The detailed analysis of these sequences allowed us to
define (i) general polymorphisms of CRF01_AE sequences, (ii)
specific polymorphisms located in intra-epitopic regions, (iii) drug
resistance mutations.
General polymorphisms. A CRF01_AE Vietnamese
natural consensus including polymorphisms present in more
than 50% of the sequences was established for Gag, RT and
Prot proteins. The percentage of homology found between the
Mekong consensus reference and the B or CRF01_AE consensus
reference (as defined in Los Alamos database) is shown in Table 1.
Our Mekong consensus sequence was in agreement with the
CRF01_AE consensus observed in untreated Southeast Asian
patients and described in previous studies, with a percentage of
homology above 98%. The percentage of homology between the
Mekong and B consensus sequences was 93.2%, 92.9% and 85.1%
for RT, Prot and Gag amino acid sequences, respectively (92.5%,
90.9% and 85.3% respectively with the HxB2 strain).
Amino Acid substitutions located in intra-epitopic
regions. Using this consensus sequence, we focused our
analysis on polymorphisms present in optimal CTL epitopes as
defined in the Los Alamos database. Figure 3 depicts the location
and HLA restriction elements of CTL epitopes on Gag and RT
sequences on HxB2 aligned with the CRF01_AE Vietnamese
consensus sequence. As there are only very few differences
between Mekong and whole CRF01_AE consensus sequences
and these differences are not relevant in terms of HLA binding
predictions, the consensus amino acid of CRF01_AE was not
added in the figure.
A detailed analysis of amino acid substitutions in epitopic
regions was assessed for RT, Gag and Prot sequences and
compared to the reference strain HxB2. A high number of amino
acid polymorphisms were detected in optimal CTL epitopes as
defined in the Los Alamos database. The analysis was accurately
performed for 106 optimal CTL epitopes displayed by Gag, RT
and Prot proteins. The proportion of divergent epitopes was
45.2% (19/42) in RT-Prot protein and 57.8% (37/64) in Gag
protein. Thirteen RT epitopes presented more than 60% of
identity with HxB2 epitopes, while 20 RT epitopes exhibited less
HIV-1 CRF01_AE Variability and Immune Recognition
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60.6% divergent RT epitopes). With regard to Gag, more than
60% of identity between Mekong and HxB2 epitope sequences
was observed for 20 epitopes. Among the 44 epitopes with low
identity, 24 were highly divergent (corresponding to a proportion
of 68.7% of the Gag epitopes).
Drug resistance mutations. According to the international
list of surveillance drug resistance mutations (SDRMs) updated in
2009 [26], we identified some drug resistance mutations (DRMs)
from 7 HIV-1 infected individuals. None of them had received any
antiretroviral treatment. The DRMs in the RT are listed in
Table 2. These DRMs are demonstrated to be unrelated
to polymorphism, and are associated with nucleoside reverse
Figure 2. Phylogenic analysis of RT sequences of 125 Vietnamese HIV-1 patients.
doi:10.1371/journal.pone.0026244.g002
Table 1. Percentage of homology between CRF01_AE
Vietnamese consensus sequences of RT, Prot and Gag aligned
with the consensus CRF01_AE or B strain.
Mekong RT Mekong Prot Mekong Gag
CRF01_AE consensus 99.1% 99.0% 84.6%
B consensus 93.2% 92.9% 85.1%
doi:10.1371/journal.pone.0026244.t001
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reverse transcriptase inhibitors (NNRTIs) (98G, 103N, 106I,
181C, 181I, 188V, 190A, 230L).
In addition, the protease-coding region carried minor resistance
mutations to protease inhibitors (PIs) (for example 36I) reflecting
natural polymorphism in non-B subtypes. The major DRM 46I
was observed in one patient but this mutation can be considered as
a polymorphism in CRF01_AE [26].
HLA Class I typing
HLA class I typing was performed for 116 patients. The number
of different HLA-A, HLA-B and HLA-Cw alleles detected in this
study was 21, 42 and 21 respectively. The five most frequent HLA
class I alleles in the Mekong population are represented in
Figure 4 and are compared to three other populations:
Vietnamese, Chinese and Caucasian people.
The most frequent HLA-A allele was A*11:01, followed by
A*24:02, A*33:03 and A*02:03, with a frequency of 23.7%, 13.8%,
10.3%, and 9.4%, respectively. A*02:07 and A*29:01 were also
common with a frequency of 6.9% and 5.9%, respectively. The
most frequent HLA-B allele was B*15:02, followed by B*38:02,
B*07:05 and B*46:01 present in 14.5%, 8.5%, 8% and 7.5% of the
population, respectively. B*15:12 and B*58:01 were found at a
frequency of 5%. Among HLA Cw alleles, Cw*08:01, Cw*07:02,
Cw*01:02, Cw*03:04 and Cw*03:03 were predominant with a
frequency of 17.6%, 15.7%, 11.1%, 8.3% and 7.9%, respectively.
Moreover, we calculated the linkage disequilibrium in this
population and found that most of the pairwise associations were
statistically significant with a p value,0.001. The most frequent
two-locus haplotypes were B*15:02-Cw*08:01 (23.3%
2), B*38:02-
Cw*07:02 (14.7%) and B*46:01-Cw*01:02 (12.1%). The two most
Figure 3. Comparison of Gag (A) and RT (B) Vietnamese consensus sequences with HxB2 strains. Optimal CTL epitopes are highlighted
by boxes. HLA restriction is indicated on the corresponding epitopes. Amino acid substitutions are indicated in bold. Shaded vertical bars separate
blocks of 10 amino acids.
doi:10.1371/journal.pone.0026244.g003
Table 2. Drug resistance mutation (DRM) in RT sequences
according to the international list of surveillance drug-
resistance mutations (SDRMs) updated in 2009 [26].
Sample ID RT DRMs NRTI and NNRTI resistance
DN-M3 230L NVP, EFV
DT-M8 181C NVP, EFV
DT-M9 65R, 181C TDF, NVP, EFV
DT-M12 103N, 190A NVP, EFV
DT-M15 184V, 181I 3TC, NVP, EFV
DT-M24 103N NVP, EFV
DT-M19 98G, 106I, 181C, 188V NVP, EFV, ETV
NVP=nevirapine, EFV=efavirenz, TDF=tenofovir, 3TC=lamivudine,
ETV=etravirine.
doi:10.1371/journal.pone.0026244.t002
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and A*29:01-B*07:05-Cw*15:05 with a frequency of 9.5%.
Epitope Processing and HLA-binding predictions
We then investigated amino acid divergences observed within
CTL epitopes in the 105 Vietnamese RT-Prot and Gag sequences
according to each individual’s HLA restriction elements. We
found 50 epitopes of interest presenting one to three divergences.
The processing into the cell as well as the binding to HLA
molecules of each divergent CTL epitope described in the
Vietnamese sequences was predicted through the proteasome,
TAP and MHC scores (Figure 5). The scores for the divergent
epitopes were matched and compared with those obtained with
the CTL epitopes described for subtype B. The analysis was
performed extensively for each HLA restriction element whenever
the HLA allele was available on the immune epitope database.
Forty-seven different HLA-restricted epitopes could be analyzed
(Table 3). Comparisons of the three scores in each group of
epitopes are presented in Figure 4. Proteasome and TAP scores
were comparable in divergent and wild-type epitopes, with a mean
(6 SD) of 1.29 (60.3) in each group for the proteasome score and
a mean (6 SD) of 0.43 (60.26) for wild-type epitopes vs 0.44
(60.27) for divergent epitopes. The differences were not
significant. MHC scores were significantly lower in divergent
epitopes with a mean of 2.4 (60.9) vs 2( 60.7) in wild-type epitopes
(p,0.0001). To refine the results, we analyzed the data according
to the IC50 of each epitope (provided on the IEDB database) based
on the rough guideline that peptides with IC50 values ,50 nM are
considered as having high affinity, between 50 and 500 nM as
having intermediate affinity and above 500 nM as having low
affinity. A strong change in ranking affinity was obtained for 15
epitopes presenting amino acid changes compared to wild-type
(highlighted in grey in Table 3). The binding affinity evaluated by
the MHC score was decreased in 11 out of the 15 epitopes with a
mean of 23.18 (60.85) for the divergent epitopes vs 22.04
(60.57) for the wild-type epitopes (p,0.0001). In 4 out of the 15
epitopes, the MHC score was slightly increased with a mean of
21.6 (60.15) for the divergent epitopes vs 21.57 (60.31) for the
wild-type epitopes (p not significant).
Discussion
HIV-1 diversity is modulated at the population level by host
immune pressure, which induces a high rate of divergence in
immunodominant epitopes recognized by the prevalent HLA class
I alleles in these populations. CTL escape mutations occur at
critical sites within HLA-restricted CTL epitopes. Indeed, an
amino acid substitution may abrogate epitope-HLA binding,
reduce T-cell receptor recognition, impair antigen processing or
generate antagonistic CTL responses [27]. These mutations result
in CTL immune escape but could lead to a severe fitness cost to
the virus [28]. Thus, determining the exact kinetics and dynamics
of the duel between host and virus is always a challenge. When
HIV is transmitted from person to person, mutational escape and
reversion rapidly shape HIV evolution. The present global HIV-1
diversity is the result of cumulative infections followed by intra-
host viral evolution. The gold standard to analyze it is to provide a
comprehensive immunologic and virologic analysis in the context
of an acute infection [29]. Due to the difficulty of identifying very
early cases of HIV transmission, this type of study is rare.
The present study focused on MHC class I antigen presentation
of optimal CTL HIV-1 epitopes across a chronically infected
HLA-diverse host population. The patients were HIV-1 infected,
all but 3 were ART-naı ¨ve, and they all lived in five provincial cities
in the Mekong Delta, Vietnam. As expected, our phylogenetic
analyses confirmed that HIV-1 CRF01_AE is the unique strain
circulating in Southern Vietnam. In addition, DRMs could be
detected even in a naive population. The analysis of DRMs on
RT-Prot sequences showed 7 ARV-resistant mutants (mostly to
NNRTI) among 122 ART-naive patients (6.7%). These results are
Figure 4. HLA allele frequencies in the Vietnamese Mekong Delta population (n=116) compared to Kinh Vietnamese (dashed bars),
Chinese (grey bars) and European (white bars) populations. The 6 most representative HLA alleles of the Mekong Delta population are
represented.
doi:10.1371/journal.pone.0026244.g004
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showing a prevalence of 4.4% detected for RTI mutations in
contrast with a prevalence of 1.7% for PI. This percentage may be
explained by the still limited use of PI in Vietnam [19]. We had no
information regarding NNRTI use by the corresponding patients
for prevention of mother-to-child transmission, which raises the
hypothesis that these mutations are SDRMs transmitted from
treated to untreated individuals. Since the prevalence is above 5%
corresponding to the threshold of surveillance for WHO, our
results should be an argument for initiating longitudinal surveys of
resistance in the southern part of the country.
The predominance of the CRF01_AE strain is not surprising.
Indeed, since the first case of HIV-1 infection detected in Ho Chi
Minh City in 1990, the CRF01_AE strain is still largely
predominant in Vietnam. Our study is the first to provide data
on HIV-1 subtypes in the Mekong area where we identified only
the CRF01_AE circulating form. However, there have been a few
other studies describing HIV-1 genotypes in other regions of
Vietnam such as Ho Chi Minh city, Hanoi and Hai Phong among
similar cohorts. In all of them, CRF01_AE predominates although
a few other subtypes have been identified such as B’ [20] and some
recombinants as CRF01_AE/B’ [30], CRF02_AG/D [30] and
CRF01_AE/C [31].
This wide predominance of CRF01_AE despite individual
genetic variability and continuous human influx and efflux
remains to be understood. One possible explanation could be a
more efficient transmission of the virus. Interestingly, a study in a
longitudinal cohort of injection-drug users in Thailand conducted
from 1995 through 1998 found an increased probability of
transmission of CRF01_AE as compared with subtype B, though it
was unclear whether epidemiologic, virologic or host factors were
affecting viral spread [32]. In this study, our goal was to evaluate
the importance of host factors in the predominance of this viral
strain.
The genetic factors of the Vietnamese population living around
the Delta Mekong were analyzed according to the distribution of
HLA-A, B, and Cw alleles and haplotypes by high-resolution DNA
typing. Although there have been some studies on HLA typing in
the Vietnamese population, there is only one comprehensive four-
digit typing report of HLA class I alleles harbored by the Kinh
population in Vietnam, the most prevalent ethnic group in the
country [22]. Our results are consistent with the latter study. We
clearly show that HLA A*11:01 and B*46:01, which are depicted
as Asian alleles, are widely present in our cohort with a high
predominance of HLA A*11:01 among HLA-A alleles, whereas
the prevalence of both alleles is about 5.6% and 0% in European
people, respectively [23]. Other alleles such as A*29:01, B*07:05
and B*15:12 appear to be more specific to the Vietnamese
population with a frequency above 5% compared to a frequency
below 0.5% in Chinese and European populations [23]. The two
major three-digit haplotypes are A*29:01-B*07:05-Cw*15:04
(9,5%) and A*29:01-B*07:05-Cw*15:05 (9,5%), which are consid-
ered by Hoa and colleagues as a Kinh signature [22].
Interestingly, even if our population is very similar to the Kinh
one, it differs with regard to one specific allele, HLA B*15:12. This
allele is absent in the Kinh population and other Vietnamese
ethnic populations like the Uyghur [33], Jinua and Wa [34]. It has
been described as having a very low frequency (lower than 2.5%)
in other Asian populations such as the Chinese, Yi and Hani
populations [35]. As this is the first paper reporting such a
Figure 5. Comparisons of proteasome, TAP and MHC scores between wild-type (B sub-type) and divergent epitopes (CRF01_AE
sequences). All scores are logarithmic values, high values corresponding to highly predicted efficiency.
doi:10.1371/journal.pone.0026244.g005
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HLA
Protein
location
Wild Type
Epitope
Prot.
Score
TAP
Score
MHC
Score MHC IC50[nM]
Mutated
Epitope
Prot.
Score
TAP
Score
MHC
Score
MHC
IC50[nM]
A*24:02 p17 KYKLKHIVW 1,66 0,45 -2,15 142,8 KYHMKHIVW 1,6 0,46 22,15 142
KYRLKHIVW 1,66 0,47 22,33 212,9
KYRMKHIVW 1,6 0,47 22,38 237,4
KYRMKHLVW 1,56 0,47 22,08 121
QYKLKHIVW 1,66 0,38 22,63 422,3
RYRMKHLVW 1,56 0,48 21,99 98,4
B*35:01 p17 HSSQVSQNY 1,31 1,26 21,98 95,2 SSSKVSQNY
b 1,31 1,3 23,23 1690,9
B*40:01 p17 IEIKDTKEAL 1,56 0,44 22,61 402,8 IDIKDTKEAL
b 1,56 0,38 24,22 16458
IDVKDTKEAL
b 1,56 0,38 24,32 20736
IEVKDTKEAL
b 1,56 0,44 22,91 819
IQVKDTKEAL
b 1,56 0,49 24,37 23631,4
A*02:01 p17 SLYNTVATL 1,54 0,51 21,72 53 SLFNLVATL
a 1,55 0,48 21,4 25,1
SLFNTIATL
a 1,55 0,48 21,57 37
SLFNTVATL
a 1,54 0,48 21,66 45,9
A*26:01 p24 EVIPMFSAL 1,41 0,39 21,21 16,3 EVIPMFTAL
b 1,48 0,39 21,93 85,5
B*07:02 p24 TPQDLNTML 1,58 0,27 22,72 526,8 TPQDLNMML 1,57 0,27 22,96 920,8
B*53:01 p24 QASQEVKNW 1,47 0,36 22,32 209,7 QATQEVKNW 1,47 0,35 22,29 193,1
B*57:01 p24 QASQEVKNW 1,47 0,36 22,43 270,5 QATQEVKNW 1,47 0,35 22,56 360,5
B*57:01 p24 TSTLQEQIGW 1,4 0,38 21,94 87,2 TSNLQEQIGW
b 1,4 0,35 23,24 1719,2
B*58:01 p24 TSTLQEQIGW 1,4 0,38 21,62 41,4 TSNLQEQIGW 1,4 0,35 22,01 102,3
A*02:01 RT ALVEICTEM 0,94 0,22 22,14 138,1 ALTEICKEM
b 1,06 0,17 22,96 907,6
ALIEICTEM 0,94 0,22 21,81 64
A*02:01 RT VIYQYMDDL 1,16 0,53 22,7 500,1 IIYQYMDDL 1,16 0,51 22,64 439
A*02:01 RT ILKEPVHGV 0,95 0,13 22,12 132 ILKTPVHGV 1,03 0,13 22,45 281
A*03:01 RT AIFQSSMTK 0,91 0,33 21,28 18,9 AIFQCSMTK 0,91 0,33 21,4 25,2
A*11:01 RT AIFQSSMTK 0,91 0,33 20,94 8,6 AIFQCSMIK 0,83 0,33 21,15 14,1
AIFQCSMTK 0,91 0,33 21,1 12,5
AIFQSSMTR
b 1,06 0,77 21,89 77,1
A*11:01 RT IYQEPFKNLK 0,85 0,21 23,34 2179,4 IYQEPFRNLK 0,86 0,21 23,23 1699,2
IYQEPFKNLR 1,01 0,65 24,37 23411
INQEPFKNLK 0,85 0,15 23,57 3751,1
IFQEPFKNLK 0,85 0,2 23,12 1303,6
IYQETFKNLK 0,85 0,21 23,34 2209,6
A*11:01 RT QIIEQLIKK 0,91 0,22 21,91 81,2 QIIEELIKK 0,91 0,22 22,01 102,6
QIVEELIKK 0,91 0,23 22,37 234,4
QVIEELIKK 0,91 0,23 22,37 234,4
A*26:01 RT ETKLGKAGY 1,28 1,19 21,87 73,6 ENKQGKAGY
b 1,2 1,16 23,01 1023,6
ETRLGKAGY 1,28 1,21 21,82 66,2
ETRLGKAGY 1,28 1,21 21,82 66,2
B*08:01 RT GPKVKQWPL 1,11 0,26 22,06 115 GPKVRQWPL
a 1,11 0,26 21,76 57,1
B*57:01 RT IVLPEKDSW 1,39 0,41 22 100,7 IELPEKDSW
b 1,39 0,39 22,86 718,8
B*58:01 RT IAMESIVIW 1,53 0,42 20,73 5,4 IATESIIIW 1,48 0,37 21,02 10,5
IATESIVIW 1,53 0,37 211 0
IVTESIVIW 1,53 0,38 21,67 46,4
IAIESIIIW 1,48 0,42 20,79 6,2
IATEGIIIW 1,48 0,37 21,25 17,6
Wild type epitope scores are matched with the corresponding divergent epitope score (Prot. score=proteasome score).
aEpitopes for which amino acid divergence induces improved MHC binding.
bEpitopes for which amino acid divergence decreases MHC binding.
doi:10.1371/journal.pone.0026244.t003
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as a genetic signature of this population living in the Mekong Delta
of Vietnam.
This remarkable diversity and specificity of the HLA class I
molecules clearly shape immune responses individually, as the
HLA-class I molecules play an important role in CD8+ T-cell
recognition. However, the relative impact of these forces on the
evolution of HIV at the population level is difficult to evaluate. It
has been suggested that virus-clade-specific differences could
result, at least in part, from the impact of HLA differences between
populations living in distinct regions of the world. Indeed, escape
mutations within CD8+ T-cell epitopes can be transmitted
relatively frequently and persist in HIV-mismatched recipients,
thereby accumulating over time to ultimately represent the most
prevalent form of the virus [14], [36], [37], [38].
In our study, we aimed to analyze the impact of divergences
within CTL epitopes located in Gag and RT-Prot among
Vietnamese HIV-1 strains on HLA class I binding recognition.
Results were compared to HLA class I binding recognition of wild-
type CTL epitopes from the reference HxB2. Our analysis shows
that there is a high degree of polymorphism of CRF01_AE strains
compared to the HxB2 reference strain or subtype B strain.
Divergences within CRF01_AE CTL epitopes did not modify
antigen processing as evaluated by TAP and proteasome scores.
However, MHC binding was drastically reduced in two thirds of
the divergent epitopes identified, and when the amino acid
divergence increased it, the rise was modest. So far, viral escape
via mutations within CTL epitopes has been well documented. In
most cases, the mutation occurred within the epitope, leading
either to reduced binding to the MHC class I molecule and/or an
alteration of T-cell receptor recognition. A few mutations affecting
antigen processing have also been reported in portable flanking
sequences [39].
In our study, all predictions of HLA class I presentation were
conducted using T-cell predictions from the Immune Epitope
DataBase, but the impact of the divergences we identified on the
CTL response could not be assessed, as patients’ peripheral blood
lymphocytes were not available for such in vitro experiments [39].
Therefore, even if these predictions were made using experimental
data, they should be interpreted with extreme caution. Proteasome
score is the logarithm of the total amount of cleavage site usage
releasing the peptide C-terminus. It does not take into account
other factors such as the amount of source protein degraded, the
type of cell involved in the protein degradation [40] or the amount
of immunoproteasome. Moreover, as this software was set up with
a limited number of HLA alleles A and B, we could not analyze
several alleles that were common in our Vietnamese population,
such as: A*33:03, A*02:07, A*29:01, B*38:02, B*07:05 and
B*15:12. No data were available for HLA-Cw alleles.
Furthermore, in the absence of in vitro analysis, notably ELISpot,
compensatory and new CTL responses could not be detected [41]
nor could cross-reactive immune responses, as has been shown with
subtype A, CRF01_AE and CRF02_AG [42]. Finally, we cannot
rule out that the divergences observed in epitopes are chance
occurrences, are compensatory, or that they could be due to co-
variance and not only result from immune pressure.
However, despite these limitations and in the context of a
chronic infection, we demonstrate that in a homogeneous HLA
diverse population from the Mekong Delta, Vietnam, MHC
binding of known CTL epitopes seems to be strongly reduced due
to intraepitopic mutations, thereby facilitating immune evasion of
Vietnamese HIV-1 strains. This weak immune pressure combined
with a low genetic diversity could explain why CRF01_AE has
emerged and spread so rapidly in Southern Asia since 1990.
This finding emphasizes the importance of the immune system
in shaping HIV-1 evolution in vivo at a population level, as already
demonstrated in previous papers. Moore et al. elegantly showed
that particular host HLA class I alleles are clearly associated with
polymorphisms in HIV-1 at sites of least functional or structural
constraint, whereas absence of polymorphism is also HLA allele–
specific [43]. Other studies suggest that escape mutations within
CD8+ T-cell epitopes are frequently transmitted and persist in
HIV-mismatched recipients, thereby accumulating over time to
ultimately represent the most prevalent form of the virus [37].
More recently, Kawashima et al. demonstrated that the frequency
of the mutations present in epitopes associated with viral control is
strongly correlated with the prevalence of the restricting HLA
allele in 9 distinct extensive cohorts [44]. All these data confirm
that HIV can adapt to HLA control in order to evade CD8+ T-cell
responses and highlight the challenge to find a vaccine to keep
pace with the evolving virus.
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